Bios Partners related stories
All articles and analysis
Actuate Therapeutics gathers $6.5 mlnFort Worth, Texas-based Actuate Therapeutics Inc, a clinical stage biopharmaceutical company, has raised $6.5 million in financing. Bios Partners led the round with participation from other investors that included Kairos Ventures and DEFTA Partners.
- Azitra fetches $14 mln Series A
Farmington, Connecticut-based Azitra Inc, a clinical-stage medical dermatology company addressing serious skin conditions by harnessing the microbiome, has raised $14 million in Series A financing. KdT Ventures and Bios Partners led the round with participation from Connecticut Innovations and Godfrey Capital.
- Trefoil reels in $28 mln
San Diego-based Trefoil Therapeutics, a biotech firm, has secured $28 million in financing. Bios Partners led the round with participation from other investors that included Access Biotechnology, Hatteras Venture Partners, Aju IB Investment, Correlation Ventures, ExSight Ventures and InFocus Capital Partners.
- Actuate Therapeutics inks $21.7 mln Series B
Fort Worth, Texas-based Actuate Therapeutics Inc, a clinical stage biopharmaceutical company, has raised $21.7 million in Series B financing. Kairos Ventures led the round with participation from DEFTA Partners, Tech Coast Angels and Bios Partners.
- Actuate Therapeutics inks $21.7 mln Series B
Fort Worth, Texas-based Actuate Therapeutics Inc, a clinical stage biopharmaceutical company, has raised $21.7 million in Series B financing. Kairos Ventures led the round with participation from DEFTA Partners, Tech Coast Angels and Bios Partners.
- Azitra pockets $2.15 mln
Farmington, Connecticut-based Azitra Inc, a biotech company focused on harnessing the microbiome to treat skin disease, has raised $2.15 million in financing. Connecticut Innovations and Bios Partners were the lead investors. Also, KdT Ventures participated in the round.